This robotics startup raised $75 million to automate drug manufacturing. See the pitch deck.
Source: Business Insider ·
A robotics startup raised $75 million to automate manufacturing for complex medicines. See the pitch deck it used.
From the source
Multiply Labs CEO Fred PariettiMultiply LabsMultiply Labs raised $75 million to automate drug manufacturing.Its robots make complex drugs like gene therapies and mRNA treatments.Its pitch deck shows how it pitched investors, including Founders Fund and AstraZeneca.AI can help discover new medicines, but making them is another story. Multiply Labs, a robotics startup based in San Francisco, wants to solve that.The company, which builds robots for manufacturing complex drugs, announced on Tuesday that it raised $75 million in a Series B funding round, bringing its total funding to more than $100 million since its founding in 2016. The round was led by NantWorks, a holding company founded by billionaire Patrick Soon-Shiong. Other investors include AstraZeneca, a Multiply customer, Lux Capital, and Founders Fund."Someone has to make the drugs," Multiply CEO Fred Parietti told Business Insider. The company's office, which I visited this summer, is a large warehouse in the Dogpatch…